Short answer
SMI blue chips dominate Swiss equity perception. They offer quality and liquidity, but also create concentration risk.
In this guide
What it means
Large Swiss companies often have global revenue, strong brands and defensive characteristics. That does not mean they move together or carry the same risks.
How to use it
Investors can use blue chips as individual holdings, index exposure or a quality screen before deeper company analysis.
Investor checklist
Check sector weight, revenue geography, balance-sheet strength, dividend policy, valuation and whether your portfolio already owns similar global exposure.
Frequently asked questions
What should I remember?
Swiss blue chips are high-quality anchors, but they are not a full diversification plan.
Where does this fit in the portfolio?
They can serve as core equity exposure or as a Swiss quality sleeve.
What is the main risk?
The main risk is overconcentration in a few pharma and consumer names.
